Pharma Journalist - Page 119 of 957 -

Cognizant Extends Gilead Partnership to Expand AI-Enabled DevOps

CSL, Alentis Partner on $1.55B Kidney and Liver Drug

Alector Licenses Parkinson’s Drug Program to Genentech for $1.27B

Nemluvio Approved in EU for Atopic Dermatitis and Prurigo Nodularis

MaxCyte Signs Platform License with TG Therapeutics for Autoimmune Cell Therapies

Health Canada Approves Merck’s KEYTRUDA for Resectable NSCLC with Chemotherapy

Lundbeck’s Amlenetug for MSA Receives FDA Fast Track Designation

AbbVie and Xilio Therapeutics Partner to Develop Tumor-Activated Immunotherapies

Boehringer’s Nerandomilast Hits Primary Endpoint in Phase III FIBRONEER-ILD for Pulmonary Fibrosis

Novartis Strengthens Cardiovascular Pipeline with $925 Million Anthos Therapeutics Acquisition

Bio-Thera Solutions Signs Exclusive License Deal with Intas for BAT2506 Biosimilar in the U.S.

Biodexa Secures FDA Fast Track Designation for eRapa in Familial Adenomatous Polyposis

Immuneering Signs Clinical Supply Deal with Regeneron to Test IMM-1-104 with Libtayo